Brind.

BioServe and Axiom Space Partner on $10M NASA Stem Cell Research Grant

1 report, 1 independent Updated Thu 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

NASA awarded a $10 million In Space Production Applications grant to fund research conducted by Cedars-Sinai Center for Space Medicine Research. BioServe Space Technologies and Axiom Space will conduct projects over six missions spanning four years. These experiments will test whether microgravity improves the production of stem cell-derived structures, such as heart and brain organoids, in space.

From newswise.com

Why it matters

Some supportBrind's analysis of the reports

The grant supports advanced biomedical research by exploring the advantages of creating complex biological structures in a microgravity environment. This work is relevant to both the commercialization of space missions and the development of new medical treatments.

From newswise.com

Who's involved

  • BioServe Space TechnologiesPartnering on space research missions and receiving grant funding
  • Axiom SpacePartnering on space research missions and receiving grant funding
  • Arun SharmaCo-investigator on the newly awarded NASA grant

Who could feel it

Possible knock-on effects

These are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.

  • BioServe Space TechnologiesSpeculative

    Could see increased revenue and contracts from the $10 million NASA grant.

  • Axiom SpaceSpeculative

    Could see increased revenue and contracts from the $10 million NASA grant.

  • Clive SvendsenSpeculative

    Might see increased research funding and project scope due to the grant.

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped